USE OF A NOVEL EMBRYONIC MAMMARY STEM CELL GENE SIGNATURE TO IMPROVE HUMAN BREAST CANCER DIAGNOSTICS AND THERAPEUTIC DECISION MAKING
$238,375FY2012Department of DefenseDOD
University Of North Carolina At Chapel Hill, Chapel Hill NC
University Of North Carolina At Chapel Hill, Chapel Hill NC